MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF METHYLPHENIDATE OR SALTS THEREOF
The present invention relates to modified release pharmaceutical compositions of methylphenidate or salts thereof. In particular, the present invention relates to modified release pharmaceutical compositions comprising at least one immediate release and at least one extended release component of met...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to modified release pharmaceutical compositions of methylphenidate or salts thereof. In particular, the present invention relates to modified release pharmaceutical compositions comprising at least one immediate release and at least one extended release component of methylphenidate or salts thereof. The composition may provide extended and specific release of methylphenidate or salts thereof to achieve therapeutically effective plasma concentration over a period of 12 hours to treat attention deficit disorders when administered to a patient in need thereof. The invention also includes process of preparing such composition. |
---|